ACLX

Arcellx (ACLX)

About Arcellx (ACLX)

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Gaithersburg, MD.

Details

Daily high

$82.99

Daily low

$81.60

Price at open

$81.65

52 Week High

$88.66

52 Week Low

$30.88

Market cap

4.5B

Dividend yield

0.00%

Volume

26,633

Avg. volume

510,653

P/E ratio

-77.00

Arcellx News